UBS Group AG - AOXING PHARMACEUTICAL CO INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of AOXING PHARMACEUTICAL CO INC
ValueSharesWeighting
Q3 2017$4,000
-42.9%
22,423
-2.3%
0.00%
Q2 2017$7,000
-12.5%
22,945
-10.2%
0.00%
Q4 2016$8,000
+166.7%
25,556
+471.1%
0.00%
Q3 2016$3,000
-57.1%
4,475
-55.6%
0.00%
Q2 2016$7,000
+600.0%
10,070
+572.7%
0.00%
Q1 2016$1,000
-95.5%
1,497
-95.4%
0.00%
Q4 2015$22,00032,224
+146372.7%
0.00%
Q4 2014$0220.00%
Other shareholders
AOXING PHARMACEUTICAL CO INC shareholders Q4 2017
NameSharesValueWeighting ↓
Rotella Capital Management, Inc. 30,499$53,0000.04%
Evercore Wealth Management, LLC 13,158$23,0000.00%
BlackRock Fund Advisors 105,895$185,0000.00%
BlackRock Investment Management, LLC 6,274$11,0000.00%
Tower Research Capital LLC (TRC) 8$00.00%
AQR Capital Management 45,700$80,0000.00%
View complete list of AOXING PHARMACEUTICAL CO INC shareholders